Literature DB >> 11432962

Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.

J M Pace1, C D Kuslich, M C Willing, P H Byers.   

Abstract

Type I procollagen is a heterotrimer comprised of two proalpha1(I) chains and one proalpha2(I) chain. Chain recognition, association, and alignment of proalpha chains into correct registration are thought to occur through interactions between the C-terminal propeptide domains of the three chains. The C-propeptide of each chain contains a series of cysteine residues (eight in proalpha1(I) and seven in proalpha2(I)), the last four of which form intra-chain disulphide bonds. The remaining cysteine residues participate in inter-chain stabilisation. Because these residues are conserved, they are thought to be important for folding and assembly of procollagen. We identified a mutation (3897C-->G) that substituted tryptophan for the cysteine at position 1299 in proalpha1(I) (C1299W, the first cysteine that participates in intra-chain bonds) and resulted in mild osteogenesis imperfecta. The patient was born with a fractured clavicle and four rib fractures. By 18 months of age he had had no other fractures and was on the 50th centile for length and weight. The proband's mother, maternal aunt, and grandfather had the same mutation and had few fractures, white sclerae, and discoloured teeth, but their heights were within the normal range. In the patient's cells the defective chains remained as monomers for over 80 minutes (about four times normal) and were overmodified. Some secreted procollagens were also overmodified but had normal thermal stability, consistent with delayed, but normal helix formation. This intra-chain bond may stabilise the C-propeptide and promote rapid chain association. Other regions of the C-propeptide thus play more prominent roles in chain registration and triple helix nucleation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432962      PMCID: PMC1757177          DOI: 10.1136/jmg.38.7.443

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Interchain disulfide bonds in procollagen are located in a large nontriple-helical COOH-terminal domain.

Authors:  P H Byers; E M Click; E Harper; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  Role of the pro-alpha2(I) COOH-terminal region in assembly of type I collagen: disruption of two intramolecular disulfide bonds in pro-alpha2(I) blocks assembly of type I collagen.

Authors:  S A Doyle; B D Smith
Journal:  J Cell Biochem       Date:  1998-11-01       Impact factor: 4.429

3.  Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.

Authors:  J Bonadio; K A Holbrook; R E Gelinas; J Jacob; P H Byers
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

4.  Identification of disulfide bonds in carboxy-terminal propeptides of human type I procollagen.

Authors:  J Koivu
Journal:  FEBS Lett       Date:  1987-02-23       Impact factor: 4.124

5.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

6.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

7.  Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation.

Authors:  T Pihlajaniemi; L A Dickson; F M Pope; V R Korhonen; A Nicholls; D J Prockop; J C Myers
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

8.  Nucleotide sequences of complementary deoxyribonucleic acids for the pro alpha 1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution.

Authors:  M P Bernard; M L Chu; J C Myers; F Ramirez; E F Eikenberry; D J Prockop
Journal:  Biochemistry       Date:  1983-10-25       Impact factor: 3.162

9.  COOH-terminal propeptides of the major human procollagens. Structural, functional and genetic comparisons.

Authors:  A S Dion; J C Myers
Journal:  J Mol Biol       Date:  1987-01-05       Impact factor: 5.469

10.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.

Authors:  J Bonadio; P H Byers
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

View more
  21 in total

1.  Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.

Authors:  Shawna M Pyott; Ulrike Schwarze; Helena E Christiansen; Melanie G Pepin; Dru F Leistritz; Richard Dineen; Catharine Harris; Barbara K Burton; Brad Angle; Katherine Kim; Michael D Sussman; Maryann Weis; David R Eyre; David W Russell; Kevin J McCarthy; Robert D Steiner; Peter H Byers
Journal:  Hum Mol Genet       Date:  2011-01-31       Impact factor: 6.150

2.  The heterozygous disproportionate micromelia (dmm) mouse: morphological changes in fetal cartilage precede postnatal dwarfism and compared with lethal homozygotes can explain the mild phenotype.

Authors:  Robert E Seegmiller; Brandon D Bomsta; Laura C Bridgewater; Cindy M Niederhauser; Carolina Montaño; Sterling Sudweeks; David R Eyre; Russell J Fernandes
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

3.  Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase.

Authors:  Stephan Baumann; Thierry Hennet
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

4.  A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.

Authors:  J M Pace; D Chitayat; M Atkinson; W R Wilcox; U Schwarze; P H Byers
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

5.  Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta.

Authors:  Yasemin Alanay; Hrispima Avaygan; Natalia Camacho; G Eda Utine; Koray Boduroglu; Dilek Aktas; Mehmet Alikasifoglu; Ergul Tuncbilek; Diclehan Orhan; Filiz Tiker Bakar; Bernard Zabel; Andrea Superti-Furga; Leena Bruckner-Tuderman; Cindy J R Curry; Shawna Pyott; Peter H Byers; David R Eyre; Dustin Baldridge; Brendan Lee; Amy E Merrill; Elaine C Davis; Daniel H Cohn; Nurten Akarsu; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

6.  Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.

Authors:  David R Deyle; Iram F Khan; Gaoying Ren; Pei-Rong Wang; Jordan Kho; Ulrike Schwarze; David W Russell
Journal:  Mol Ther       Date:  2011-10-25       Impact factor: 11.454

7.  Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta.

Authors:  Helena E Christiansen; Ulrike Schwarze; Shawna M Pyott; Abdulrahman AlSwaid; Mohammed Al Balwi; Shatha Alrasheed; Melanie G Pepin; Mary Ann Weis; David R Eyre; Peter H Byers
Journal:  Am J Hum Genet       Date:  2010-02-25       Impact factor: 11.025

8.  COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.

Authors:  Aileen M Barnes; Aarthi Ashok; Elena N Makareeva; Marina Brusel; Wayne A Cabral; MaryAnn Weis; Catherine Moali; Emmanuel Bettler; David R Eyre; John P Cassella; Sergey Leikin; David J S Hulmes; Efrat Kessler; Joan C Marini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

9.  Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta.

Authors:  Joel R Chamberlain; David R Deyle; Ulrike Schwarze; Peirong Wang; Roli K Hirata; Yi Li; Peter H Byers; David W Russell
Journal:  Mol Ther       Date:  2007-10-23       Impact factor: 11.454

10.  Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases.

Authors:  Rong Chen; Lisong Shi; Jörg Hakenberg; Brian Naughton; Pamela Sklar; Jianguo Zhang; Hanlin Zhou; Lifeng Tian; Om Prakash; Mathieu Lemire; Patrick Sleiman; Wei-Yi Cheng; Wanting Chen; Hardik Shah; Yulan Shen; Menachem Fromer; Larsson Omberg; Matthew A Deardorff; Elaine Zackai; Jason R Bobe; Elissa Levin; Thomas J Hudson; Leif Groop; Jun Wang; Hakon Hakonarson; Anne Wojcicki; George A Diaz; Lisa Edelmann; Eric E Schadt; Stephen H Friend
Journal:  Nat Biotechnol       Date:  2016-04-11       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.